Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
ELISA Kit for Bone Morphogenetic Protein 1 (BMP1)
PCOLC; PCP; TLD; mTld; Procollagen C Proteinase; Mammalian tolloid protein
- Product No.SEA653Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample Typeserum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length3h
- Detection Range15.6-1,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 6.3pg/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 441
For more details, please contact local distributors! US$ 630 US$ 2835 US$ 5355 US$ 44100
Specificity
This assay has high sensitivity and excellent specificity for detection of Bone Morphogenetic Protein 1 (BMP1).
No significant cross-reactivity or interference between Bone Morphogenetic Protein 1 (BMP1) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Bone Morphogenetic Protein 1 (BMP1) and the recovery rates were calculated by comparing the measured value to the expected amount of Bone Morphogenetic Protein 1 (BMP1) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 88-96 | 92 |
EDTA plasma(n=5) | 78-90 | 85 |
heparin plasma(n=5) | 82-90 | 86 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Bone Morphogenetic Protein 1 (BMP1) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Bone Morphogenetic Protein 1 (BMP1) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Bone Morphogenetic Protein 1 (BMP1) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 81-102% | 97-105% | 95-102% | 93-101% |
EDTA plasma(n=5) | 78-92% | 78-101% | 94-103% | 79-96% |
heparin plasma(n=5) | 79-97% | 99-105% | 91-99% | 82-101% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.
GIVEAWAYS
INCREMENT SERVICES
- Single-component Reagents of Assay Kit
- Lysis Buffer Specific for ELISA / CLIA
- Quality Control of Kit
- ELISA Kit Customized Service
- Disease Model Customized Service
- Serums Customized Service
- TGFB1 Activation Reagent
- Real Time PCR Experimental Service
- Streptavidin
- Fast blue Protein Stain solution
- Single-component Reagents of FLIA Kit
- Streptavidin-Agarose Beads
Magazine | Citations |
Nat Commun | Bone morphogenetic protein 1.3 inhibition decreases scar formation and supports cardiomyocyte survival after myocardial infarction Pubmed:35013172 |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
RPA653Hu01 | Recombinant Bone Morphogenetic Protein 1 (BMP1) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA653Hu01 | Polyclonal Antibody to Bone Morphogenetic Protein 1 (BMP1) | WB; IHC; ICC; IP. |
LAA653Hu81 | FITC-Linked Polyclonal Antibody to Bone Morphogenetic Protein 1 (BMP1) | WB; IHC; ICC; IF. |
LAA653Hu71 | Biotin-Linked Polyclonal Antibody to Bone Morphogenetic Protein 1 (BMP1) | WB; IHC; ICC. |
MAA653Hu22 | Monoclonal Antibody to Bone Morphogenetic Protein 1 (BMP1) | WB; IHC; ICC; IP. |
SEA653Hu | ELISA Kit for Bone Morphogenetic Protein 1 (BMP1) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA653Hu | Multiplex Assay Kit for Bone Morphogenetic Protein 1 (BMP1) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |